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The investigation of venoms has many clinical, pharmacological, ecological and evolutionary outcomes.
The Crotalus spp. venom can cause hemorrhage, neurotoxicity, myotoxicity, coagulopathy and hypo-
tension. Although neurotoxicity and hemorrhage usually does not occur for the same species, the rare
Venezuelan species Crotalus vegrandis presents both characteristic. Different from the other species it has
a restricted ecological niche and geographical distribution. Nevertheless, it has a raising medical
importance as this rattlesnake population is increasing. Few works describe its neurotoxic and hemor-
rhagic features, but other toxins might play an important role in envenomation. We combined proteomic
methods to identify for the ﬁrst time the main components of it venom: 2D SDS-PAGE and gel-ﬁltration
chromatography for protein mixture decomplexation; LC-MS2 of low molecular mass fractions and
tryptic peptides; bioinformatic identiﬁcation of toxin families and speciﬁc protein species based on
unique peptide analysis and sequence database enriched with species-speciﬁc venom gland transcripts;
and ﬁnally polyclonal anti-crotamine Western-blotting. Our results point to a broad arsenal of toxins in
C. vegrandis venom: PIII and PII metalloproteases, crotoxin subunits, other phospholipases, isoforms of
serine proteases and lectins, L-amino-acid oxidase, nerve growth factor, as well as other less abundant
toxins.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Rattlesnakes (Viperidae: Serpentes) are native predators from
the Americas whose most popular feature is the noisy rattle used ase venom metalloproteinase;
id oxidase; CLP, C-type lectin-
; PDE, venom phosphodies-
retory protein; VNGF, venom
glutathione peroxidase; EXE,a ﬁrst defense against predators (Campbell and Lamar, 2004;
Klauber, 1997). The study of their venoms led to the discovery of
interesting new molecules, studied under a multidisciplinary
fashion that integrates pharmacological, biotechnological, physio-
logical and evolutionary points of view (Calvete, 2013; Campbell
and Lamar, 2004; Harvey and St€ocklin, 2012). In general, toxins
from Crotalus snakes can cause hemorrhage, neurotoxicity, myo-
toxicity, coagulopathy and hypotension (Azevedo-Marques et al.,
2003; Gutierrez, 2009; Mackessy, 2008; Markland, 1983). Based
on the main systemic characteristics of envenomation, Mackessy
(2008) observed distinct venom phenotypes and classiﬁed the
Crotalus spp. in two groups, the type I, hemorrhagic, and the type II,
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the other. Although type II appears to be more abundant in South
America, while the type I in northern and central part of the
continent, exceptions were described. South American exceptions
to this classiﬁcation are Crotalus durissus ruruima (Dos Santos et al.,
1993), C. d. cumanensis (Cavalcante et al., 2015; Yoshida-Kanashiro
et al., 2003) and Crotalus vegrandis (Giron et al., 2005), whose
venoms display both hemorrhagic and neurotoxic activities. North
and Central American exception are the species Crotalus scutulatus
scutulatus (Massey et al., 2012), Crotalus viridis/oreganus complex
(Mackessy, 2010), Crotalus horridus (Glenn et al., 1994), Crotalus
simus (Castro et al., 2013) and Crotalus tigris (Calvete et al., 2012).
Within a single species, populations can exhibit many different
venom phenotypes, such as C. scutulatus scutulatus that displays six
different phenotypes based on variations of three toxin families:
neurotoxic phospholipase A2 (PLA2), snake venom metal-
loproteinase (SVMP) and myotoxin (Massey et al., 2012), or such as
C. horriduswhere some individuals even lack both hemorrhagic and
neurotoxic features (Glenn et al., 1994). Not least than the toxicity
vs. hemorrhagic phenotype discussion, exploring the hidden di-
versity of toxins that might play an important role in envenomation
is of great relevance for the design and preclinical assessment of
antivenoms (Calvete et al., 2014).
The “Cascabel de Uracoa” has a restricted distribution at the
central-west of the region of plateaus in Monagas and Anzoategui
States of Venezuela, in a small area of semiarid savannas (Pifano
and Rodríguez Acosta, 1996). Its habitat is different from the
other Crotalus species as it can only be found in a speciﬁc ecological
niche: small relictual forested areas with a speciﬁc microclimate,
not being found in desert areas, wetlands or in degraded areas,
even in the dry ones. It is a nocturnal predator and its diet is mainly
based on small lizards (Anolis sp. and Tropidurus sp.) but recent
agricultural activities introduced vermin in its diet (Pifano and
Rodríguez Acosta, 1996). Its ecology, biology and habits are poorly
studied and its conservation status is “marginal at best” (quote
from Pifano and Rodríguez Acosta, 1996).
Twenty deaths caused by snakebite accident were registered
between 1980 and 2000 in the Monagas State (De Sousa et al.,
2005). An epidemiological survey upon snake accidents regis-
tered at the Manuel Nu~nez Tovar Hospital from Monagas State
(Navarro et al., 2004), analyzed 53 crotalic accidents out of 158
snakebite accidents, over 10 years. In 36 out of the 53 crotalic ac-
cidents (68%), the snakewas captured and identiﬁed as C. vegrandis.
Based on previous studies, they concluded that the prevalence of
crotalic envenomation was higher in Monagas state than in other
Venezuelan regions. They discussed that in some regions the
environment has changed increasing food availability, increasing
the population size and the incidence of observed accidents.
Little is known about the C. vegrandis clinical features of en-
venomation. According to Rodríguez-Acosta et al. (1995), enve-
nomed animals showed an intense general hemorrhage,
respiratory difficulties and death by possible paralysis of the res-
piratory muscles. Few data indicate that this venom has an LD50 of
0.2 mg/g (i.v.) (Scannone et al., 1978) and 0.5 mg/g (i.m.) (Rodriguez-
Acosta et al., 1998) in mice and that the hemorrhagic and neuro-
toxic activities (Gubensek et al., 1978; Rodriguez-Acosta et al., 1998;
Scannone et al., 1978) can be ascribed to metalloproteases (Aguilar
et al., 2001) and to a crotoxin-like heterodimer (Giron et al., 2005)
respectively. An accident casewas reported, inwhich a great edema
of the affected limb was described with no apparent neurological
signals (Pifano and Rodríguez Acosta, 1995).
In this work, we analyzed for the ﬁrst time the venom general
composition of the Uracoan rattlesnake C. vegrandis. We performed
a high throughput proteomic analysis based on mass spectrometry
(MS), complemented with further experiments such as thedetection of crotamine-like proteins by western-blotting and cDNA
cloning and sequencing for snake venom serine proteases (SVSPs).
2. Materials and methods
2.1. Venom
Venoms of ﬁve captive individuals of C. vegrandis were pooled
and provided by Venom Supplies Pty. Ltd. (Tanunda, Australia).
After milking, the venoms were immediately freeze-dried and
stored at 20 C.
2.2. Venom decomplexation and MS analysis
2.2.1. 2D gel, in-gel digestion and MS
Prior to use, the sample was dissolved up to 170 mg/mL (9 M
urea, 70 mM DTT and 2% ampholytes), incubated (30 min at room
temperature), centrifuged (45 min, 15000 g) and the supernatant
removed and frozen at 80 C. The 2D-PAGE was performed and
stained using slightly adapted method from previous works (Viala
et al., 2014). Selected spots were collected manually. In-gel diges-
tion was performed with Trypsin (Promega) according to the
manufacturer's instructions. The peptides were subsequently
analyzed by LC/ESI/ion trap/MSeMS analysis (Agilent 1100 LC/
MSD-trap XCT series system) (Viala et al., 2014).
2.2.2. Gel ﬁltration (GF) chromatography, in-solution digestion and
MS
Thirty mg of crude venom were dissolved in 500 mL of
ammonium formiate (100 mM, pH 3.0). After centrifugation, the
clear supernatant was injected in a Superdex 75 10/300 (GE
Healthcare) column previously equilibrated with the same buffer,
connected to an €Akta puriﬁer system (GE Healthcare). Elution was
performed at 0.6 mL/min and the absorbance was monitored at
220 and 280 nm. One milliliter fractions were collected and pooled
according to the chromatogram. Lyophilized fractions were
redissolved in 1 mL of ammonium bicarbonate (50 mM pH 7.4)
and incubated 1 h at 45 C in additional 50 mL of denaturation
buffer (20 mM TrisHCl; 7 M Urea; 5 mM DTT; 2 mM EDTA). Di-
sulﬁde bonds were reduced for 1 h by adding 10 mL of DTT (5 mM
in 25 mM ammonium bicarbonate) and cysteine were alkylated in
the dark for 1 h by adding 10 mL of iodoacetamide (55 mM in
25 mM ammonium bicarbonate). Proteins were digested overnight
with 15 mL of 20 ng/mL Trypsin (Promega) (50 mM ammonium
bicarbonate). The samples were dried and stored in 20 C until
further steps. Samples were redissolved in 0.1% formic acid (sol-
vent A), injected in a C18 reverse phase (Supelco, 3 mm, 100 Å,
50 mm  2.1 mm) and eluted with a 5e40% gradient of solvent B
(90% acetonitrile/H2O with 0.1% formic acid) in 40 min, at a con-
stant ﬂow rate of 0.2 mL/min. The HPLC eluates were monitored
by a Shimadzu SPD-M20A PDA detector scanning from 200 to
500 nm (1 nm steps). MS spectra were acquired on a IT-ToF
(Shimadzu Co, Japan) under positive mode, interface voltage at
4.5 kV, detector voltage at 1.76 kV, interface temperature at
200 C, and collected in the 50e2000 m/z range. MS/MS spectra
was obtained by argon gas collision and obtained in a range of
50e2000 m/z. The fractions containing low molecular-weight
proteins were not trypsinized.
2.3. Protein identiﬁcation and detection of protein species by
unique peptides (UP) screening
The raw mass spectra ﬁles were converted to “.mgf” ﬁles for
bioinformatic analysis. Protein identiﬁcation was performed with
PEAKS studio 7.0 (Ma et al., 2003) using the InChorus multi-
V.L. Viala et al. / Toxicon 107 (2015) 234e251236algorithmic tool (PEAKS þ MASCOT) for better accuracy. The
identiﬁcation was based on public protein and genetic databases.
The MS/MS identiﬁcationwas revised manually for score, quality of
the mass spectra and correctness of assignments. In order to get the
most of the data, an additional step was performed with PEAKS
using all sample spectra together in a unique run. This is particu-
larly useful for screening the data to locate UPs. UPs contain
stretches of unique amino acid sequences present in a database of
sequences. The PEAKS programmers deﬁne a UP as “[… ] a peptide
with its 10 logP score above the peptide ﬁltering threshold that
can be mapped to only one protein group” (Ma et al., 2003).
Therefore, UPs were located in the resulting PEAKS tables within
“Protein Groups” containing only one “Protein ID” entry. The se-
quences were then individually aligned to public protein databases
to exclude false positives and to correctly assign speciﬁc protein
species to the sample analyzed.
2.4. Crotamine-like proteins detection using western blot
immunoassays
A sample of C. vegrandis venom (33.3 mg/lane) was submitted to
15% SDS-PAGE under non-reducing conditions (Laemmli,1970). The
C. d. terriﬁcus venom (33.3 mg/lane) was used as a positive control.
The gel was placed in the electroblot apparatus adjacent to nitro-
cellulose paper in buffer, as described by Towbin et al. (1979), and
transferred for 90 min at 0.85 mA/cm2. The membrane was blocked
with 3% skim milk in pH 7.4 phosphate buffered saline and incu-
bated with rabbit polyclonal antibodies against whole crotamine
(diluted 1:8000) (Oguiura et al., 2000). The immunoreactive pro-
teins were detected using peroxidase-labeled anti-rabbit IgG and
the blot was developed with 0.05% diaminobenzidine in the pres-
ence of 0.03% H2O2 (v/v).
2.5. Venom gland cDNA library construction and SVSP transcript
cloning and sequencing
The venom gland was extracted from an adult C. vegrandismale
individual, born in captivity at Venom Supplies Pty. Ltd. (Tanunda,
Australia). The venom gland was extracted three days after milking
to obtain a tissue with a high level of toxin transcript expression. It
was stored in RNA-Later® (QIAGEN N.V., Netherlands) at 80 C
until RNA extraction. The animal was euthanized for tissue collec-
tion in accordance with Euthanasia of Animals Used for Scientiﬁc
Purposes guidelines (2001), Australian and New Zealand Council
for the Care of Animals in Research and Teaching, under the
monitoring of the SA Pathology/CHN Animal Ethics Committee,
Project Approval 93/12. The total RNA was extracted with Trizol®
reagent (Life Technologies, USA) in an RNAse free environment. A
cDNA library of the venom gland mRNA was built using In-Fusion
SMARTer cDNA library construction kit (Clontech Laboratories
Inc., USA). The SVSP cDNA was ampliﬁed by PCR using a set of
primers designed based on conserved regions found in Viperidae
SVSP: FUTRgyr (50-CAGAGTTGAAGCTATGGTGCTGAT -30) and R6gyr
(50- TGCACCTCACCCTAAAACAGG -30). A 20 mL reaction mix con-
tained 14 ng DNA sample, 0.1 mM each primer, 0.5 U Taq DNA
polymerase Platinum (Invitrogen), buffer with the addition of
1.5 mM MgCl2, and 0.2 mM dNTPs mix. The ampliﬁcation process
used an initial denaturation step of 4 min at 94 C, followed by 30
cycles of 45 s at 94 C, 45 s at 60 C, 45 s at 72 C, and, ﬁnally 1 min
at 72 C. The ampliﬁed DNAwas puriﬁed, after electrophoresis on a
1% agarose gel, using the Zymoclean Gel DNA Recovery kit
(ZymoResearch). The puriﬁed DNA was cloned into the pTZ57 R/T
vector according to the manufacturer's instructions (Fermentas).
After transformation of E. coli DH5a (Ausubel et al., 2000), clones
were puriﬁed using Zyppy Plasmid Miniprep (ZymoResearch).Sequencing was performed at the Biotechnology Center in the
Butantan Institute, on an ABI Prism 3500 Genetic Analyzer (Applied
Biosystems), using the M13 (50-GTAAAACGACGGCCAGT-30) and T7
(50-TAATACGACTCACTATAGGG -30) primers.
3. Results
3.1. Venom protein identiﬁcation by MS
The 2D electrophoresis detected components ranging from pI 3
to 10 and molecular mass ranging from 14 to 120 kDa (Fig. 1).
Multiple horizontal trains of spots are observed. A total of 73
spots were collected for analysis from different regions of the gel.
Protein families were assigned to 65 spots such as basic and acidic
PLA2, including crotoxin subunits; SVMP (PIII and PII); SVSP, such as
gyroxin-like and others; C-type lectin-like proteins (CLP), including
a convulxin-like toxin; cysteine-rich secretory protein (CRiSP);
ecto-50-nucleotidase (E50N); venom nerve growth factor (VNGF);
phospholipase B (PLB); venom phosphodiesterase (PDE) and
exendin-4 like peptides (EXE). Glutathione peroxidase (GP) and
carboxypeptidase E-like (CPE) were identiﬁed as well (Table 1).
The complementary MS analysis of GF fractionated venom
(Fig. 2) resulted in the additional identiﬁcation of bradykinin-
potentiating peptides (BPPs), bradykinin inhibitory peptide (BIP),
C-type natriuretic peptide (CNP) and the crotoxin acidic subunit
(Table 2).
3.2. Crotamine-like immunodetection
The Western blot cross-species assay performed with an anti-
crotamine polyclonal antibody (Oguiura et al., 2000) was positive
indicating the existence of a homologous toxin in C. vegrandis
venom (Fig. 3).
3.3. SVSP cloning and sequencing
A 1027 bp PCR fragment, named SVSPcv01, was sequenced
(GenBank: KT266708) (Supplementary material). It includes the
open reading frame and partial 30 untranslated region. A search at
BLASTn, using the cDNA sequence, matches to other SVSP of Cro-
talinae snakes with c.a. 90% of identity. The translated primary
sequence is 258 residues long (Fig. 4). Domain prediction analysis
(Jones et al., 2014; Petersen et al., 2011) identiﬁed it as a peptidase
S1 trypsin-like cysteine/serine protein, and detected an 18 residue
long signal peptide and three peptidase S1A chymotrypsin-type
subfamily domain signature (Fig. 4).
4. Discussion
The C. vegrandis venom is known to be highly hemorrhagic
(local and systemic bleeding are major signs of Uracoan rattlesnake
envenomation) and neurotoxic (causing death by respiratory pa-
ralysis) (Giron et al., 2005; Gubensek et al., 1978; Rodriguez-Acosta
et al., 1998; Scannone et al., 1978). A neurotoxic fraction described
by Kaiser and Aird (1987) contains crotoxin-like proteins. A hem-
orrhagic fraction containing SVMP was also described (Aguilar
et al., 2001). Myotoxic activity was also reported (Pulido-Mendez
et al., 1999) and Bober et al. (1988) suggested the existence of a
crotamine-like toxin.
A more accurate description of this venom composition is
important for appropriate treatment of accidents (Castro et al.,
2013; Gutierrez et al., 2014; Saviola et al., 2015; Sunagar et al.,
2014). Additionally to the epidemiological and medical impor-
tance, many snake venom molecules are targets for innovative
development in pharmacology and biotechnology (e.g. Barnwal and
Fig. 1. 2D-PAGE of Crotalus vegrandis venom. Identiﬁed clusters of spots and individual spots are labeled. Circles represent identiﬁed spots and crosses represent collected spots with
no signiﬁcant result. pI: isoelectric point; kDa: molecular weight; SVMP III: PIII snake venom metalloproteinase; SVMP II: PII snake venom metalloproteinase; SVMP: unclassiﬁed
snake venom metalloproteinase; SVSP: snake venom serine protease; LAAO: L-amino acid oxidase; CLP: C-type lectin-like proteins; PLA2: snake venom phospholipase A2; PDE:
venom phosphodiesterase; PLB: phospholipase B; CRiSP: cysteine rich secretory protein; VNGF: venom nerve growth factor; CPE: carboxypeptidase-E; GP: glutathione peroxidase;
EXE: exendin-like peptides.
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components of C. vegrandis venom from a qualitative point of view,
our data might contribute to a better understanding of Crotalus spp.
ecology and evolution. Other Crotalus ssp. from adjacent
geographical location, such as C. d. ruruima and C. d. cumanensis,
have similar venom compositions, showing both hemorrhagic and
neurotoxic activities (Aguilar et al., 2007; Calvete et al., 2010;
Cavalcante et al., 2015; Dos Santos et al., 1993). Thus, there must
be some positive evolutionary pressure to favor this phenotype.
4.1. Crotoxin-like toxins and other PLA2
The neurotoxic crotoxin was ﬁrst described by Slotta andFraenkel-Conrat (1938) as the main component of C. d. terriﬁcus
venom. Crotoxin is a beta-neurotoxin, acting pre-synaptically on
muscular junctions blocking the signal transduction (Degn et al.,
1991). Crotoxin is heterodimeric, composed by a nontoxic acidic
subunit (crotapotin) acting as a chaperone, delivering the basic
PLA2 subunit to the synaptic cleft, blocking the release of acetyl-
choline. Although non-toxic, the acidic subunit is essential to
neurotoxic activity as the isolated basic subunit has low toxicity
(Bon, 1982). Peptides matching to crotoxin basic subunit were
detected in spots 1, 2 and 49, in a vertical cluster, ranging from ~17
to ~28 kDa at pI 10 (Fig. 1) and in other isolated spots (7 and 43). LC/
MSeMS analyses of the GF low molecular mass fraction (not
trypsinized) showed the presence of peptides derived from N and
Table 1
Summary table of Crotalus vegrandis venom LC-MS/MS identiﬁcation on 2D-PAGE spots. Data generated by PEAKS þMASCOT (InChorus) analysis. Bold peptide sequences are
Unique Peptides. M(þ15.99): Oxidation of methionine. m: mass; z: charge; SVMP: snake venom metalloproteinase; SVSP: snake venom serine protease; LAAO: L-amino acid
oxidase; CLP: C-type lectin-like proteins; PLA2: snake venom phospholipase A2; PDE: venom phosphodiesterase; PLB: phospholipase B; CRiSP: cysteine rich secretory protein;
VNGF: venom nerve growth factor; CPE: carboxypeptidase-E; GP: glutathione peroxidase; EXE: exendin-like peptides.
Spot Prot. family Score (%) Top hit description Accession Hit species Peptide m/z z





















3 CRiSP 84.14 Cysteine-rich seceretory
protein Ch-CRPKa
(Fragment)
F2Q6E5_CROHD Crotalus horridus R.SVNPTASNMLK.M 581.3 2
SVDFDSESPR.K 569.75 2














4 SVSP 61.97 Kallikrein-CohLL-4 T1DEH3_CROOH Crotalus oreganus
helleri
R.FLVALYTFR.S 565.33 2
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Table 1 (continued )






























7 SVSP 61.3 Snake venom serine
protease homolog
(Fragment)
VSPH_CROAT Crotalus atrox R.FLVALYTFR.S 565.36 2
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Table 1 (continued )
Spot Prot. family Score (%) Top hit description Accession Hit species Peptide m/z z




























13 SVSP 84.94 Snake venom serine
protease catroxase-1








15 SVMP 61.63 SVMP-CohPH-3 T1E6U1_CROOH Crotalus oreganus
helleri
R.M(þ15.99)YELANTVNDIYR.Y 809.43 2
16 CLP 61.41 Snaclec crotocetin SL_CRODU Crotalus durissus
terriﬁcus
K.QDMTWEDAEK.F 626.84 2










18 SVSP 98.87 Snake Venom Serine
Protease clone 1
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Table 1 (continued )
Spot Prot. family Score (%) Top hit description Accession Hit species Peptide m/z z













27 CRiSP 98.38 Cysteine-rich seceretory
protein Ch-CRPKa
(Fragment)











27 SVSP 95.27 Serine proteinase 5 T1DGZ7_CROHD Crotalus horridus R.IMGWGTISATK.E 583.02 2
R.AAHGGLPATSR.T 519.27 2
K.WDKDIMLIR.L 595.41 2
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Table 1 (continued )
Spot Prot. family Score (%) Top hit description Accession Hit species Peptide m/z z





































































43 SVSP 61.3 Snake venom serine
protease catroxase-2
VSP2_CROAT Crotalus atrox K.KVPNEDEQTR.V 608.35 2













47 CLP 61.38 Snaclec crotocetin-1 SL1_CRODU Crotalus durissus
terriﬁcus
K.YYVWIGLR.I 535.3 2
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Table 1 (continued )
Spot Prot. family Score (%) Top hit description Accession Hit species Peptide m/z z







51 CRiSP 98.38 Cysteine-rich seceretory
protein Ch-CRPKa
(Fragment)
F2Q6E5_CROHD Crotalus horridus K.MEWYPEAAANAER.W 769.42 2
SVDFDSESPR.K 569.79 2
R.SVNPTASNMLK.M 581.27 2












































































60 EXE 61.48 Exendin-4 EXE4_HELSU Heloderma
suspectum
R.HGEGTFTSDLSK.Q 639.85 2
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Table 1 (continued )










67 SVMP 61.66 Metalloproteinase P-II Q2QA03_CRODD Crotalus durissus
durissus
R.VAVTMTHELGHNLGIR.H 583.41 3










72 VNGF 61.53 NGF-CohID-1 (Fragment) T1DEA2_CROOH Crotalus oreganus
helleri
R.ALTM(þ15.99)EGNQASWR.F 690.4 2
73 CLP 60.6 Snaclec crotocetin-1 SL1_CRODU Crotalus durissus
terriﬁcus
K.GAHLVSVESAGEADFVAQLVAENIK.Q 852.18 3
Fig. 2. Gel ﬁltration chromatogram of 30 mg of Crotalus vegrandis crude venom, fractionated in a Superdex 75 10/300 (GE) column. Arrows indicate the molecular weight range.
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preparation and manipulation, one cannot currently assure
whether the presence of these peptides is an artifact or that these
fragments are cryptides (Pimenta and Lebrun, 2007) with a yet
unknown function.
The crotoxin acidic subunit was identiﬁed in the GF venom
fractions. The tryptic peptide (QICECDKAAAICFR) identical to cro-
toxin acidic subunit (crotapotin) was identiﬁed in the GF fraction IV
(Table 2) and, in the low molecular fractions a UP corresponding to
its N-terminal end (G.SLVEFETLMMKIAGR.S) was detected.
Other PLA2S, different from the classical crotoxin in sequence
and activity, can also be found in rattlesnake venoms. The basic
PLA2 Cdc-9 and Cdc-10 from C. d. cumanensis present myotoxic and
edema-inducing activity (Romero-Vargas et al., 2010). An acidicPLA2 was identiﬁed in spot 22 (Fig. 1). Its sequence matches to a
PLA2 cloned from the C. d. cascavella venom gland (UniProtKB:
C9E7C4) (Guarnieri et al., 2009). The identiﬁcation of this protein
species is supported by two UPs. Examining the data for UPs also
enabled us to distinguish another protein species in spot 1 (Fig. 1;
Table 1), a basic PLA2 named LmTX-II from Lachesis muta muta
(Damico et al., 2005).
4.2. SVMP
Snake venommetalloproteases are a multigene enzymatic toxin
family in which the diversity of gene products can induce hemor-
rhage, ﬁbrin(ogen)olysis, apoptosis, as well as activate blood
coagulation factor X, inactivate blood serine protease inhibitors,
Table 2
Summary table of Crotalus vegrandis venom LC-MS/MS identiﬁcation of gel-ﬁltration fractions. Data generated by PEAKS þ MASCOT (InChorus) analysis. Bold peptide se-
quences are Unique Peptides. M(þ15.99): Oxidation of methionine; C(þ57.02): Carbamidomethylation of cysteine; m: mass; z: charge; SVMP III: PIII snake venom metal-
loproteinase; SVMP II: PII snake venom metalloproteinase; SVSP: snake venom serine protease; LAAO: L-amino acid oxidase; PLA2: snake venom phospholipase A2; VNGF:
venom nerve growth factor; BPP: bradykinin-potentiating peptide; BIP: bradykinin inhibitory peptide; CNP: C-type natriuretic peptide.
Prot. Family Score (%) Top hit description Accession Hit species Peptide m/z z
Fraction I











































































SVMP II 59.58 Metalloproteinase P-II Q2QA03_CRODD Crotalus durissus
durissus
R.VAVTMTHELGHNLGIR.H 583.32 3
SVMP III 56.51 Snake venom
metalloprotease






















60.91 Phospholipase A2 1b T1E3Y3_CROHD Crotalus horridus K.QIC(þ57.02)EC(þ57.02)DKAAAIC
(þ57.02)FR.E
871.41 2
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Table 2 (continued )








VNGF 59.22 NGF-CohPH-1 T1E7J7_CROOH Crotalus oreganus
helleri
T.DQHYPAPK.K 478.23 2
Fraction VI þ VII þ VIII
crotoxin PLA2
basic









59.73 Phospholipase A2 homolog










Fig. 3. Western blotting of Crotalus vegrandis (right lane) and C. durissus terriﬁcus
(control) crude venoms (both 33.3 mg/lane) against polyclonal anti-crotamine (1:8000
dilution).
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(Markland and Swenson, 2013). SVMPs are classiﬁed in PI, PII and
PIII classes according to their domain composition. So far, the only
SVMP described in C. vegrandis venom is a hemorrhagic fraction
puriﬁed by Aguilar et al. (2001), named Uracoine-1, with an esti-
mated mass of 58 kDa under denaturing conditions. In this work,
PIII and PII SVMPs were observed. PIII peptides from Crotalus spe-
cies were identiﬁed in venom fractions and in a cluster of spots
ranging from ~50 kDa to ~70 kDa and pI around 5 (Fig. 1, Table 1,
Table 2). A UP was detected in spot 10, indicating the existence of a
crotastatin-like isoform. Crotastatin, also known as VAP1, is a
vascular apoptosis-inducing protein ﬁrst described in Crotalus atrox
(Masuda et al., 1997). The expression of homologous transcripts
was also detected in C. d. cascavella, Bothrops atrox and L. m.Fig. 4. Translated amino acid sequence (258 residues) of the SVSPcv01 transcript cloned fro
identiﬁed: peptidase S1 trypsin-like cysteine/serine (underlined sequence); signal peptide (
(gray boxes). The catalytic triad residues are indicated with ◊ symbol.rhombeata (Tavares et al., 2008). Another UP matching to a PIII was
detected in spots 36 and 55. It matches to a transcript described in
C. d. durissus venom gland (Azofeifa-Cordero et al., 2008).
PII peptides were identiﬁed in venom fractions and in the 2D gel,
in spot 21 and in a cluster formed by the spots 39, 40, 56 and 63
(Fig. 1, Table 1, Table 2). In all those spots, the identiﬁcation of a C. d.
durissus PII gene product (UniProtKB: Q2QA03) was supported by
UPs. Interestingly, the spots 39 and 56, belonging to this PII spot
cluster, contain a UP derived from a PIII cloned from the Colubridae
Philodryas olfersii (Ching et al., 2006).
Two spots (15 and 67), with much lower mass, were also iden-
tiﬁed as SVMPs. Their position in the gel suggests the existence of PI
SVMPs in the venom, but their tryptic peptide sequences align
better with PII and PIII sequences thanwith PI. Those spots could be
products of PII and PIII proteolysis.4.3. SVSP
Snake venom serine proteases are a multigene family that is
present in almost all families of venomous snakes. Despite their
apparent similarity, the isoforms have diversiﬁed activities on the
coagulation cascade, i.e. factor V, factor X, protein C and plasmin-
ogen activation, thrombin-like activity on ﬁbrinogen, induction of
platelet aggregation, and also prothrombin activation and action on
the kallikrein-kinin system (Serrano, 2013). SVSPs were identiﬁed
in spots 3, 4, 12, 13, 18, 27, 29, 30, 38, 53, 58, 59, 60 and 61. The spot
60 contains a UP from the isoform B1.4 of gyroxin (Yonamine et al.,
2009). Gyroxin is a toxin from C. d. terriﬁcus, which has similar tom a Crotalus vegrandis venom gland (GenBank: KT266708). Domain prediction analysis
crosshatched box); and peptidase S1A chymotrypsin-type subfamily domain signatures
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of ﬁbrinogen to ﬁbrin (Barrabin et al., 1978; Barrio, 1961). It also
induces the barrel rotation syndrome in mice, probably by
increasing reversibly the permeability of the blood brain barrier
(Alves da Silva et al., 2011). Based on two UPs, we also identiﬁed in
spot 59 a speciﬁc gene product cloned from the Central American
C. d. durissus (UniProtKB: Q2QA04).
The gene product SVSPcv01 we have cloned from C. vegrandis
venom gland transcripts was identiﬁed in spot 18. The identiﬁca-
tion is supported by the UP sequence R.EPGVYVK.V (residue 230 to
236;m/z¼ 791.46; z¼ 1) indicating it is secreted in the venom. The
ﬁrst ﬁve hits from the protein BLAST analysis of the SVSPcv01 full
sequence resulted in matches with Crotalus SVSP transcripts. These
hit sequences were obtained from C. horridus and Crotalus oreganus
venom glands without further characterization (Rokyta et al., 2013;
Fry, unpublished). Identity values range from 94.6% to 87.6%. We
looked for sequences with described activity and found it has 86.5%
identity with the thrombin-like enzyme asperase found in Bothrops
asper venom (Perez et al., 2008). The most similar Crotalus
sequence hit (82% of identity), is catroxase-2 from C. atrox venom,
described as a kallikrein-like SVSP (Bjarnason et al., 1983).
In general, the matching SVSPs we identiﬁed by proteomics are
expected to have ﬁbrino(gen)olityc activity, as they show high
homology with other SVSP with such features such as shedaoenase
from Agkistrodon shedaoenthesis (Jiao et al., 2005), calobin from
Gloydius ussuriensis (Hahn et al., 1996), and crotalase from Crotalus
adamanteus that additionally shows kinin-releasing activities
(Markland et al., 1982).
4.4. CLP
Snake C-type lectins are non-enzymatic toxins classiﬁed into
snake lectins, which are classic sugar binding proteins, and snake
CLPs mostly found in Viperidae, lacking the sugar-binding loop.
CLPs are composed by heterodimers with homologous a and b
subunits (Du and Clemetson, 2009). CLPs are important compo-
nents in the highly hemorrhagic venoms of the Viperidae that
activate or inhibit a wide range of plasma components and blood
cells such as coagulation Factor X, Factor IX, von Willebrand factor,
GPIb-complex, GPVI, integrin a2b1 and the ﬁbrinogen receptor
integrin aIIbb3 (Arlinghaus and Eble, 2012; Clemetson, 2010).
Seven spots (16, 23, 45, 47, 48, 71 and 73) ranging from 15 to 20 kDa
and from very acidic to very basic pI (Fig. 1) matched with CLPs.
Convulxin subunits were identiﬁed in spots 15, 45 and 48. Con-
vulxin is a ~84 kDa heterodimeric, disulﬁde linked tetramer (a4b4)
that induces platelet aggregation in mammals (Murakami et al.,
2003; Polgar et al., 1997). The alpha subunit was identiﬁed in this
venom by the detection of a UP (seq.: GAHLVSIK; m/z ¼ 412.76;
z¼ 2; score¼ 94.7%; #Spec¼ 2). The beta subunit was identiﬁed in
spots 45 and 48 supported by three UP (Table 1). Crotocetin was
also identiﬁed, supported by a UP, in spots 16, 71 and 73. Crotocetin
was originally cloned from C. d. terriﬁcus venom gland (UniProtKB:
Q719L8). The Trimeresurus mucrosquamatus crotocetin homologue,
mucrocetin, has in vitro platelet aggregation activity (Huang et al.,
2004).
4.5. Crotamine
Crotamine is a myotoxic peptide that induces spastic paralysis of
the hind limbs in mice (Gonçalves and Vieira, 1950) and it was ﬁrst
described in C. d. terriﬁcus venom by Gonçalves and Polson (1947).
Crotamine features were reviewed in Oguiura et al. (2005), and its
potential biotechnological and therapeutic applications by Kerkis
et al. (2014). Crotamine shows antimicrobial activity that can be
explained by its b-defensin structure (Oguiura et al., 2011; Yamaneet al., 2013) and interacts with vesicles which mimic bacterial
membranes (Costa et al., 2014) as well as affects voltage gated
potassium (KV) channels (Peigneur et al., 2012). Its low molecular
mass (4.9 kDa) and high isoelectric point (9.5) may impair its
detection using the 2D-PAGE MS2 approach, due to the limitations
of the 2D gel to small peptides (less than 14 kDa). Thus, the
immuno-detection of this toxin was an alternative to circumvent
this issue. A previous study (Scannone et al., 1978) suggests that
C. vegrandis has crotamine in lower levels than C. d. cumanensis. We
detected a weak reactive band in the Western blot assay with anti-
crotamine polyclonal antibodies (Fig. 3).
4.6. Bradykinin-potentiating peptides, Bradykinin inhibitor
peptides and C-type natriuretic peptides
BPPs are angiotensin converting enzymes (ACE) inhibitors found
in Viperidae venom, that can lead victims of envenoming to hy-
potensive shock (Camargo et al., 2012). They were ﬁrst discovered
in Bothrops jararaca by Ferreira and Rocha e Silva (1965), whose
further studies led to the development of the ﬁrst drug based on a
snake venom molecule: Captopril. It is a synthetic inhibitor of ACE
used for treatment of hypertension and heart failure (Cushman and
Ondetti, 1991). Even with this accumulated history of success, new
features are being discovered for BPPs in many different Viperidae
venoms (e.g. Gomes et al., 2007; Rioli et al., 2008) and, even in
Elapidae venom such as Naja mossambica (Munawar et al., 2014).
Usually, BPP precursors are composed by BPPs, BIP and CNP, sepa-
rated by propeptides that are cleaved into the active peptides. BIP
antagonizes the vasodilator actions of bradykinin at the B2 brady-
kinin receptor (Graham et al., 2005). CNP exhibits hypotensive and
vasodepressor activity (Schweitz et al., 1992). In the size exclusion
fractions, we identiﬁed a BIP, a CNP and propeptide sequences,
indicating the presence of BPP precursors similar to those of C. d.
collilineatus and C. d. terriﬁcus venoms. The identity of ﬁve BPPs
detected in the low molecular mass fractions by their prolinee-
proline fragment signature (MHþ ¼ 213.1) still needs to be
conﬁrmed (Menin et al., 2008).
4.7. CRiSP
Cysteine-rich secretory protein was identiﬁed in a cluster of
basic spots (3, 27, 50 and 51), ~30 kDa (Fig. 1). Although CRiSP
function is still unclear in the majority of snake venoms, some re-
searchers have shown that venom CRiSP can have an ion channel
blocking activity, such as the ﬁrst CRiSP described from Heloderma
horridum horridum lizard (Mochca-Morales et al., 1990). Smooth
muscle contraction inhibition and cyclic nucleotide-gated ion
channels inhibition activity were described for the pseudechetoxin
(Pseudechis australis) and pseudecin (Pseudechis porphyriacus)
(Yamazaki and Morita, 2004). Natrin, from Naja atra venom, has
proinﬂammatorymodulator activity (Wang et al., 2010). In a related
species C. atrox, aweakmuscle contraction inhibitionwas observed
as well (Yamazaki et al., 2003).
4.8. LAAO
L-amino-acid oxidase was identiﬁed in spots 4e8, 10, 11, 17, 27,
32, 33, 41, 42, 51, 52, 54, 62 and 70 (Fig. 1, Table 1, Table 2). The 2D
gel displays a visible cluster of LAAO spots at MW ~65 kDa and pI
from 8 to 9. Some others spots dispersed in the gel are probably
proteolytic fragments. LAAO was identiﬁed in the venom fraction
analysis as well. This toxin may contribute to the toxicity of the
venom mainly because of hydrogen peroxide production, but
recent studies indicate differently. The puriﬁed LAAO from C. d.
cascavella induces platelet aggregation or inhibits agonist-induced
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et al., 2006). UP analysis evidenced at least two different gene
product in this venom (Table 1): (1) the L-amino acid oxidase Cdc18
cloned and isolated from C. d. cumanensis (UniProtKB: K9N7B7),
with antibacterial activity (Vargas et al., 2013), is supported by the
detection of three UPs, and (2) an isoform described in the venom
of the European Vipera ammodytes ammodytes (UniProtKB: P0DI84)
(Georgieva et al., 2008).4.9. VNGF
Venom nerve growth factors are neurotrophic factors that
belong to the NGF-beta family found in snake venom (Kostiza and
Meier, 1996). VNGF was identiﬁed in acidic spots 14, 25 and 72,
below 20 kDa (Fig.1, Table 1), as well as in fraction V (Table 2). VNGF
was described in related species venom such as C. d. terriﬁcus
(Georgieva et al., 2010), C. simus (Castro et al., 2013) and venom
gland transcripts of C. adamanteus (Margres et al., 2014) and
C. horridus (Rokyta et al., 2013).4.10. E50N
Seven peptides matching to Crotalus venom ecto-50-nucleo-
tidase were detected in spot 34 (~70 kDa and pI 8) (Fig. 1). Although
E50N biological activity and further role in snake venom are notwell
understood, the presence of free purines supports the potential of
venom-induced hypotension and paralysis via purine receptors
(Dhananjaya and D'Souza, 2010). According to Hart et al. (2008)
E50N can inhibit platelet aggregation.4.11. PLB
The analysis of spot 31 (~50 kDa and pI from 8.5 to 9) identiﬁed
nine peptides matching to phospholipase B (Table 1). Common PLB
are enzymes that catalyze the hydrolysis of glycerophospholipids
and their toxin variants are present in bee as well as in snake
venoms. Venom PLB was ﬁrst isolated from Pseudechis colletti
(Bernheimer et al., 1987) and, recently, identiﬁed in Drysdalia
coronoides (Chatrath et al., 2011), Protobothrops ﬂavoviridis, Ovophis
okinavensis (Aird et al., 2013), Pseudechis guttatus (Viala et al., 2014)
and C. d. terriﬁcus (Melani et al., 2015). The PLBs found in snake and
bee venoms exist as monomers and dimers with molecular masses
of approximately 16 kDa and 35 kDa, respectively. They are known
to cause hemolysis (Bernheimer et al., 1986; Doery and Pearson,
1964).4.12. PDE
Venom phosphodiesterase are a superfamily of metalloenzymes
with diverse physiological and cellular signaling functions which
have become new therapeutic targets for treatment of various
diseases, such as Alzheimer's disease, inﬂammation, erectile
dysfunction, and cardiac or vascular-related diseases (Peng et al.,
2013). Snake venom PDEs are poorly investigated on what refers
to potential pharmacological activities, but some of these enzymes
puriﬁed from Trimeresurus stejnegeri, Daboia russelli russelli and
B. jararaca inhibited ADP-induced platelet aggregation in human
platelet-rich plasma by hydrolyzing ADP (Mitra and Bhattacharyya,
2014; Peng et al., 2011; Santoro et al., 2009). Spots 9 and 35
generated at least 16 peptides covering 22% of C. adamanteus and
C. horridus venom PDEs. The spots are situated at a high mass po-
sition in the 2D gel (~120 kDa and pI ranging from 7.5 to 8.5) in a
clear and isolated train of spots (Fig. 1).4.13. Exendin4-like peptides
Exendin-4 was identiﬁed in the spots 44, 46 and 60, based on
two peptides, one of them a UP. This peptide, described in the
Heloderma suspectum lizard venom (Eng et al., 1992), is a poly-
peptidic hormone that mimics glucagon and induces hypotension
in prey. Exendins are a family of peptides derived from secretin-like
hormones (Irwin, 2012). The antidiabetic drug Byetta® was devel-
oped based on its ability to stimulate the insulin production
(Furman, 2012).
4.14. Other venom proteins
This study also revealed other venom proteins such as gluta-
thione peroxidase and carboxypeptidase E-like. Their function in
the venom is unknown. Those proteins were recently identiﬁed
among others in C. d. terriﬁcus venom (Melani et al., 2015).
The GPwas identiﬁed in spot 26, located between 25 and 30 kDa
and pI ~9.0 (Fig. 1). GPs (EC:1.11.1.9) are enzymes that catalyze the
reduction of hydroxyperoxides by glutathione, which main func-
tion is to protect against oxidative damage of hydroxyperoxides
(Barnett and King, 1995).
CPE was identiﬁed in spot 37, CPE is classically known to be
involved in carboxyterminal peptide processing by releasing C-
terminal arginine or lysine residues from polypeptides, and could
be involved in post-translational modiﬁcation of toxins and other
venom proteins. Recent studies support that it is a multifunctional
protein that subserves many essential nonenzymatic roles acting
on many physiological and neuronal pathways (Cawley et al., 2012)
and could be engineered as a prognostic biomarker for metastasis
in endocrine and nonendocrine tumors (Lee et al., 2011).
5. Conclusion
Using themass spectrometry approach for protein identiﬁcation
we assessed for the ﬁrst time the full venom composition of the
medically important snake C. vegrandis. Besides reinforcing previ-
ous data that described both neurotoxic and hemorrhagic compo-
nents in the C. vegrandis venom, we provide a more detailed proﬁle
of this venom, identifying other PIII and PII SVMPs isoforms, other
PLA2s, SVSPs isoforms (including a newly sequenced transcript),
CLPs isoforms, LAAO isoforms, VNGF, CRiSP, E50N, PDE, GP, CPE and
peptides such as crotamine-like, BPP, BIP and CNP. The venom
components identiﬁed in this work match the local and systemic
symptoms described in the scarce clinical cases available in the
literature: neurotoxic and myotoxic effects can be ascribed to the
presence of crotoxin and crotamine-like molecules. Moreover, he-
mostatic disturb, such as hemorrhage and coagulopathies can be
induced directly or indirectly by SVMPs, SVSPs, LAAOs and even
E50N. On what refers to edema, the generation and/or release of
inﬂammatory mediators by the action of PLA2s, as well as other
pro-inﬂammatory molecules either from the venom or activated by
its components might be considered the causative agent of that
inﬂammatory symptom. These data might be helpful from both the
clinical and evolutionary point of view.
Ethical statement
The animal used in this work was euthanized for tissue collec-
tion in accordance with Euthanasia of Animals Used for Scientiﬁc
Purposes guidelines (2001), Australian and New Zealand Council
for the Care of Animals in Research and Teaching, under the
monitoring of the SA Pathology/CHN Animal Ethics Committee,
Project Approval 93/12.
V.L. Viala et al. / Toxicon 107 (2015) 234e251 249Acknowledgments
We would like to acknowledge Mr. Joaquín Sanchez and Ms.
Adelina Jara from the Brenesia scientiﬁc journal of the Museo
Nacional de Costa Rica for providing valuable literature used in this
manuscript; the Biotechnology Center at the Butantan Institute for
DNA sequencing; grant and scholarship from FAPESP (SP, Brazil)
(2010/08585-8 and 2009/10305-8) and CAPES/DAAD no 364/11
(Brazil/Germany research program).
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.toxicon.2015.09.023.
Transparency document
Transparency document related to this article can be found
online at http://dx.doi.org/10.1016/j.toxicon.2015.09.023.
References
Aguilar, I., Giron, M.E., Rodríguez-Acosta, A., 2001. Puriﬁcation and characterisation
of a haemorrhagic fraction from the venom of the Uracoan rattlesnake Crotalus
vegrandis. Biochim. Biophys. Acta 1548, 57e65.
Aguilar, I., Guerrero, B., Maria Salazar, A., Giron, M.E., Perez, J.C., Sanchez, E.E.,
Rodríguez-Acosta, A., 2007. Individual venom variability in the South American
rattlesnake Crotalus durissus cumanensis. Toxicon 50, 214e224. http://
dx.doi.org/10.1016/j.toxicon.2007.03.012.
Aird, S.D., Watanabe, Y., Villar-Briones, A., Roy, M.C., Terada, K., Mikheyev, A.S., 2013.
Quantitative high-throughput proﬁling of snake venom gland transcriptomes
and proteomes (Ovophis okinavensis and Protobothrops ﬂavoviridis). BMC
Genom. 14, 790. http://dx.doi.org/10.1186/1471-2164-14-790.
Alves da Silva, J.A., Oliveira, K.C., Camillo, M.A.P., 2011. Gyroxin increases blood-
brain barrier permeability to Evans blue dye in mice. Toxicon 57, 162e167.
http://dx.doi.org/10.1016/j.toxicon.2010.06.027.
Arlinghaus, F.T., Eble, J.A., 2012. C-type lectin-like proteins from snake venoms.
Toxicon 60, 512e519. http://dx.doi.org/10.1016/j.toxicon.2012.03.001.
Ausubel, F.M., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J., Struhl, K.,
2000. Current Protocols in Molecular Biology. John Wiley & Sons Inc., New York.
Azevedo-Marques, M.M., De Hering, S.E., Cupo, P., 2003. Acidente crotalico. In:
Cardoso, J.L.C., França, F.O. de S., Wen, F.H., Malaque, C.M.S., Haddad Jr., V. (Eds.),
Animais Peçonhentos No Brasil e Biologia, Clínica E Terape^utica Dos Acidentes.
Sarvier, S~ao Paulo, pp. 91e98.
Azofeifa-Cordero, G., Arce-Estrada, V., Flores-Díaz, M., Alape-Giron, A., 2008. Im-
munization with cDNA of a novel P-III type metalloproteinase from the rattle-
snake Crotalus durissus durissus elicits antibodies which neutralize 69% of the
hemorrhage induced by the whole venom. Toxicon 52, 302e308. http://
dx.doi.org/10.1016/j.toxicon.2008.05.023.
Barnett, Y.A., King, C.M., 1995. An investigation of antioxidant status, DNA repair
capacity and mutation as a function of age in humans. Mutat. Res. 338, 115e128.
http://dx.doi.org/10.1016/0921-8734(95)00017-Z.
Barnwal, B., Kini, R.M., 2013. Characterization of inﬂamin, the ﬁrst member of a new
family of snake venom proteins that induces inﬂammation. Biochem. J. 455,
239e250. http://dx.doi.org/10.1042/BJ20130599.
Barrabin, H., Martiarena, J.L., Vidal, J.C., Barrio, A., 1978. Isolation and character-
ization of gyroxin from Crotalus durissus terriﬁcus venom. In: Rosenberg, P.
(Ed.), Toxins: Animal, Plant and Microbial. Pergamon Press, New York,
pp. 113e133.
Barrio, A., 1961. Gyroxin, a new neurotoxin of Crotalus durissus terriﬁcus venom.
Acta Physiol. Latinoam. 11, 224.
Bernheimer, A.W., Linder, R., Weinstein, S.A., Kim, K.S., 1987. Isolation and charac-
terization of a phospholipase B from venom of Collett's snake, Pseudechis col-
letti. Toxicon 25, 547e554.
Bernheimer, A.W., Weinstein, S.A., Linder, R., 1986. Isoelectric analysis of some
Australian elapid snake venoms with special reference to phospholipase B and
hemolysis. Toxicon 24, 841e849.
Bjarnason, J.B., Barish, A., Direnzo, G.S., Campbell, R., Fox, J.W., 1983. Kallikrein-like
enzymes from Crotalus atrox venom. J. Biol. Chem. 258, 12566e12573.
Bober, M.A., Glenn, J.L., Straight, R.C., Ownby, C.L., 1988. Detection of myotoxin
alpha-like proteins in various snake venoms. Toxicon 26, 665e673.
Bon, C., 1982. Synergism of the two subunits of crotoxin. Toxicon 20, 105e109.
Calvete, J.J., 2013. Snake venomics: from the inventory of toxins to biology. Toxicon
75, 44e62. http://dx.doi.org/10.1016/j.toxicon.2013.03.020.
Calvete, J.J., Perez, A., Lomonte, B., Sanchez, E.E., Sanz, L., 2012. Snake venomics of
Crotalus tigris: the minimalist toxin arsenal of the deadliest Neartic rattlesnake
venom. Evolutionary clues for generating a pan-speciﬁc antivenom against
crotalid type II venoms. J. Proteome Res. 11, 1382e1390. http://dx.doi.org/10.1021/pr201021d.
Calvete, J.J., Sanz, L., Cid, P., Torre, P., De Flores-dı, M., Santos, M.C., Dos Borges, A.,
Bremo, A., Angulo, Y., Lomonte, B., Alape-giro, A., 2010. Snake venomics of the
Central American rattlesnake Crotalus simus and the South American Crotalus
durissus complex points to neurotoxicity as an adaptive paedomorphic trend
along Crotalus dispersal in South America research articles, pp. 528e544.
Calvete, J.J., Sanz, L., Pla, D., Lomonte, B., Gutierrez, J.M., 2014. Omics meets biology:
application to the design and preclinical assessment of antivenoms. Toxins
(Basel) 6, 3388e3405. http://dx.doi.org/10.3390/toxins6123388.
Camargo, A.C.M., Ianzer, D., Guerreiro, J.R., Serrano, S.M.T., 2012. Bradykinin-
potentiating peptides: beyond captopril. Toxicon 59, 516e523. http://
dx.doi.org/10.1016/j.toxicon.2011.07.013.
Campbell, J.A., Lamar, W.W., 2004. The Venomous Reptiles of the Western Hemi-
sphere. Comstock Pub. Associates, Ithaca.
Castro, E.N., Lomonte, B., del Carmen Gutierrez, M., Alagon, A., Gutierrez, J.M., 2013.
Intraspecies variation in the venom of the rattlesnake Crotalus simus from
Mexico: different expression of crotoxin results in highly variable toxicity in the
venoms of three subspecies. J. Proteom. 87, 103e121. http://dx.doi.org/10.1016/
j.jprot.2013.05.024.
Cavalcante, W.L.G., Ponce-Soto, L.A., Marangoni, S., Gallacci, M., 2015. Neuromus-
cular effects of venoms and crotoxin-like proteins from Crotalus durissus rur-
uima and Crotalus durissus cumanensis. Toxicon 96, 46e49. http://dx.doi.org/
10.1016/j.toxicon.2015.01.006.
Cawley, N.X., Wetsel, W.C., Murthy, S.R.K., Park, J.J., Pacak, K., Loh, Y.P., 2012. New
roles of carboxypeptidase E in endocrine and neural function and cancer.
Endocr. Rev. 33, 216e253. http://dx.doi.org/10.1210/er.2011-1039.
Chatrath, S.T., Chapeaurouge, A., Lin, Q., Lim, T.K., Dunstan, N., Mirtschin, P.,
Kumar, P.P., Kini, R.M., 2011. Identiﬁcation of novel proteins from the venom of a
cryptic snake Drysdalia coronoides by a combined transcriptomics and prote-
omics approach research articles, pp. 739e750.
Ching, A.T.C., Rocha, M.M.T., Paes Leme, A.F., Pimenta, D.C., de Fatima, D.,
Furtado, M., Serrano, S.M.T., Ho, P.L., Junqueira-de-Azevedo, I.L.M., 2006. Some
aspects of the venom proteome of the colubridae snake Philodryas olfersii
revealed from a Duvernoy's (venom) gland transcriptome. FEBS Lett. 580,
4417e4422. http://dx.doi.org/10.1016/j.febslet.2006.07.010.
Clemetson, K.J., 2010. Snaclecs (snake C-type lectins) that inhibit or activate
platelets by binding to receptors. Toxicon 56, 1236e1246. http://dx.doi.org/
10.1016/j.toxicon.2010.03.011.
Costa, B.A., Sanches, L., Gomide, A.B., Bizerra, F., Dal Mas, C., Oliveira, E.B., Perez, K.R.,
Itri, R., Oguiura, N., Hayashi, M.A.F., 2014. Interaction of the rattlesnake toxin
crotamine with model membranes. J. Phys. Chem. B 118, 5471e5479. http://
dx.doi.org/10.1021/jp411886u.
Cushman, D.W., Ondetti, M.A., 1991. History of the design of captopril and related
inhibitors of angiotensin converting enzyme. Hypertension 17, 589e592.
Damico, D.C.S., Lilla, S., de Nucci, G., Ponce-Soto, L.A., Winck, F.V., Novello, J.C.,
Marangoni, S., 2005. Biochemical and enzymatic characterization of two basic
Asp49 phospholipase A2 isoforms from Lachesis muta muta (Surucucu) venom.
Biochim. Biophys. Acta 1726, 75e86. http://dx.doi.org/10.1016/
j.bbagen.2005.05.022.
De Sousa, L., Vasquez, D., Salazar, D., Valecillos, R., Vasquez, D., Rojas, M., Parrilla-
Alvarez, P., Quiroga, M., 2005. Mortalidad en humanos por envenenamientos
causados por invertebrados y vertebrados en el Estado Monagas, Venezuela.
Invest. Clin. 46, 229e240.
Degn, L.L., Seebart, C.S., Kaiser, I.I., 1991. Speciﬁc binding of crotoxin to brain syn-
aptosomes and synaptosomal membranes. Toxicon 29, 973e988.
Dhananjaya, B.L., D'Souza, C.J.M., 2010. The pharmacological role of nucleotidases in
snake venoms. Cell Biochem. Funct. 28, 171e177. http://dx.doi.org/10.1002/
cbf.1637.
Doery, H.M., Pearson, J.E., 1964. Phospholipase B in snake venoms and bee venom.
Biochem. J. 92, 599e602.
Dos Santos, M.C., Ferreira, L.C., Da Silva, W.D., Furtado, M.F., 1993. Characterization
of the biological activities of the “yellow” and “white” venoms from Crotalus
durissus ruruima compared with the Crotalus durissus terriﬁcus venom.
Neutralizing activity of Crotalus durissus ruruima antivenins. Toxicon 31,
1459e1469.
Du, X.-Y., Clemetson, K.J., 2009. Reptile C-type lectins. In: Mackessy, S.P. (Ed.),
Handbook of Venoms and Toxins of Reptiles. CRC Press, Boca Raton, p. 521.
Eng, J., Kleinman, W.A., Singh, L., Singh, G., Raufman, J.P., 1992. Isolation and char-
acterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum
venom. Further evidence for an exendin receptor on dispersed acini from
guinea pig pancreas. J. Biol. Chem. 267, 7402e7405.
Ferreira, S.H., Rocha e Silva, M., 1965. Potentiation of bradykinin and eledoisin by
BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia
21, 347e349. http://dx.doi.org/10.1007/BF02144709.
Furman, B.L., 2012. The development of Byetta (exenatide) from the venom of the
Gila monster as an anti-diabetic agent. Toxicon 59, 464e471. http://dx.doi.org/
10.1016/j.toxicon.2010.12.016.
Georgieva, D., Arni, R.K., Betzel, C., 2008. Proteome analysis of snake venom toxins:
pharmacological insights. Expert Rev. Proteom. 5, 787e797. http://dx.doi.org/
10.1586/14789450.5.6.787.
Georgieva, D., Ohler, M., Seifert, J., von Bergen, M., Arni, R.K., Genov, N., Betzel, C.,
2010. Snake venomic of Crotalus durissus terriﬁcusecorrelation with pharma-
cological activities. J. Proteome Res. 9, 2302e2316. http://dx.doi.org/10.1021/
pr901042p.
Giron, M.E., Aguilar, I., Romero, L., Sanchez, E.E., Perez, J.C., Rodriguez-Acosta, A.,
V.L. Viala et al. / Toxicon 107 (2015) 234e2512502005. A low-cost method to test cytotoxic effects of Crotalus vegrandis (Ser-
pentes: Viperidae) venom on kidney cell cultures. Rev. Inst. Med. Trop. Sao
Paulo 47, 147e152. http://dx.doi.org/10.1590/S0036-46652005000300006.
Glenn, J.L., Straight, R.C., Wolt, T.B., 1994. Regional variation in the presence of
canebrake toxin in Crotalus horridus venom, 107, 337e346.
Gomes, C.L., Konno, K., Conceiç~ao, I.M., Ianzer, D., Yamanouye, N., Prezoto, B.C.,
Assakura, M.T., Radis-Baptista, G., Yamane, T., Santos, R.A., de Camargo, A.C.M.,
Hayashi, M.A.F., 2007. Identiﬁcation of novel bradykinin-potentiating peptides
(BPPs) in the venom gland of a rattlesnake allowed the evaluation of the
structure-function relationship of BPPs. Biochem. Pharmacol. 74, 1350e1360.
http://dx.doi.org/10.1016/j.bcp.2007.07.014.
Gonçalves, J.M., Polson, A., 1947. The electrophoretic analysis of snake venoms. Arch.
Biochem. 13, 253e259.
Gonçalves, J.M., Vieira, L., 1950. Estudos sobre venenos de serpentes brasileiras. I.
Analise eletroforetica. An. Acad. Bras. Cienc. 22, 141e150.
Graham, R.L.J., Graham, C., McClean, S., Chen, T., O'Rourke, M., Hirst, D.,
Theakston, D., Shaw, C., 2005. Identiﬁcation and functional analysis of a novel
bradykinin inhibitory peptide in the venoms of new world Crotalinae pit vipers.
Biochem. Biophys. Res. Commun. 338, 1587e1592. http://dx.doi.org/10.1016/
j.bbrc.2005.10.130.
Guarnieri, M., Melo, E., Melo, K., Albuquerque-Modesto, J., Prieto-da-Silva, A., Radis-
Baptista, G., 2009. Cloning of a novel acidic phospholipase A2 from the venom
gland of Crotalus durissus cascavella (Brazilian northeastern rattlesnake).
J. Venom. Anim. Toxins Incl. Trop. Dis. 15, 745e761. http://dx.doi.org/10.1590/
S1678-91992009000400012.
Gubensek, F., Turk, V., Drujon, B., 1978. Proteolytic and clotting enzymes in some
Venezuelan snake venoms. In: Proc. 2nd Symp. Eur. Sect. Int. Soc. Toxicol., 80,
pp. 101e105.
Gutierrez, J.M., 2009. Snake bite envenomation in Central America. In:
Mackessy, S.P. (Ed.), Handbook of Venoms and Toxins of Reptiles. CRC Press,
Boca Raton, pp. 491e507.
Gutierrez, J.M., Lomonte, B., Sanz, L., Calvete, J.J., Pla, D., 2014. Immunological proﬁle
of antivenoms: preclinical analysis of the efﬁcacy of a polyspeciﬁc antivenom
through antivenomics and neutralization assays. J. Proteom. 105, 340e350.
http://dx.doi.org/10.1016/j.jprot.2014.02.021.
Hahn, B.S., Yang, K.Y., Park, E.M., Chang, I.M., Kim, Y.S., 1996. Puriﬁcation and mo-
lecular cloning of calobin, a thrombin-like enzyme from Agkistrodon cal-
iginosus (Korean viper). J. Biochem. 119, 835e843.
Hart, M.L., K€ohler, D., Eckle, T., Kloor, D., Stahl, G.L., Eltzschig, H.K., 2008. Direct
treatment of mouse or human blood with soluble 50-nucleotidase inhibits
platelet aggregation. Arterioscler. Thromb. Vasc. Biol. 28, 1477e1483. http://
dx.doi.org/10.1161/ATVBAHA.108.169219.
Harvey, A.L., St€ocklin, R., 2012. From venoms to drugs: introduction. Toxicon 59,
433. http://dx.doi.org/10.1016/j.toxicon.2011.09.016.
Huang, K.-F., Ko, T.-P., Hung, C.-C., Chu, J., Wang, A.H.-J., Chiou, S.-H., 2004. Crystal
structure of a platelet-agglutinating factor isolated from the venom of Taiwan
habu (Trimeresurus mucrosquamatus). Biochem. J. 378, 399e407. http://
dx.doi.org/10.1042/BJ20031507.
Irwin, D.M., 2012. Origin and convergent evolution of exendin genes. Gen. Comp.
Endocrinol. 175, 27e33. http://dx.doi.org/10.1016/j.ygcen.2011.11.025.
Jiao, H.-M., Yang, L.-X., Lu, B., Wu, Y.-Q., Zhou, Y.-C., 2005. Shedaoenase, a novel
ﬁbrinogenase from the venom of Agkistrodon shedaoenthesis Zhao. Acta Bio-
chim. Biophys. Sin. Shanghai 37, 835e842.
Jones, P., Binns, D., Chang, H.-Y., Fraser, M., Li, W., McAnulla, C., McWilliam, H.,
Maslen, J., Mitchell, A., Nuka, G., Pesseat, S., Quinn, A.F., Sangrador-Vegas, A.,
Scheremetjew, M., Yong, S.-Y., Lopez, R., Hunter, S., 2014. InterProScan 5:
genome-scale protein function classiﬁcation. Bioinformatics. http://dx.doi.org/
10.1093/bioinformatics/btu031.
Kaiser, I.I., Aird, S.D., 1987. A crotoxin homolog from the venom of the Uracoan
rattlesnake (Crotalus vegrandis). Toxicon 25, 1113e1120.
Kerkis, I., Hayashi, M.A.F., Prieto da Silva, A.R.B., Pereira, A., De Sa Júnior, P.L.,
Zaharenko, A.J., Radis-Baptista, G., Kerkis, A., Yamane, T., 2014. State of the art in
the studies on crotamine, a cell penetrating peptide from South American
rattlesnake. Biomed. Res. Int. 2014, 675985. http://dx.doi.org/10.1155/2014/
675985.
Klauber, L.M., 1997. Rattlesnakes: Their Habits, Life Histories, and Inﬂuence on
Mankind, vol. 1. University of California Press.
Kostiza, T., Meier, J., 1996. Nerve growth factors from snake venoms: chemical
properties, mode of action and biological signiﬁcance. Toxicon 34, 787e806.
Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head
of bacteriophage T4. Nature 227, 680e685.
Lee, T.K., Murthy, S.R.K., Cawley, N.X., Dhanvantari, S., Hewitt, S.M., Lou, H., Lau, T.,
Ma, S., Huynh, T., Wesley, R.A., Ng, I.O., Pacak, K., Poon, R.T., Loh, Y.P., 2011. An N-
terminal truncated carboxypeptidase E splice isoform induces tumor growth
and is a biomarker for predicting future metastasis in human cancers. J. Clin.
Invest. 121, 880e892. http://dx.doi.org/10.1172/JCI40433.
Ma, B., Zhang, K., Hendrie, C., Liang, C., Li, M., Doherty-Kirby, A., Lajoie, G., 2003.
PEAKS: powerful software for peptide de novo sequencing by tandem mass
spectrometry. Rapid Commun. Mass Spectrom. 17, 2337e2342. http://
dx.doi.org/10.1002/rcm.1196.
Mackessy, S.P., 2008. Venom composition in rattlesnakes: trends and biological
signiﬁcance. In: Hayes, W.K., Beaman, K.R., Cardwell, M.D., Bush, S.P. (Eds.), The
Biology of Rattlesnakes.
Mackessy, S.P., 2010. Evolutionary trends in venom composition in the western
rattlesnakes (Crotalus viridis sensu lato): toxicity vs. tenderizers. Toxicon 55,1463e1474. http://dx.doi.org/10.1016/j.toxicon.2010.02.028.
Margres, M.J., McGivern, J.J., Wray, K.P., Seavy, M., Calvin, K., Rokyta, D.R., 2014.
Linking the transcriptome and proteome to characterize the venom of the
eastern diamondback rattlesnake (Crotalus adamanteus). J. Proteom. 96,
145e158. http://dx.doi.org/10.1016/j.jprot.2013.11.001.
Markland, F.S., 1983. Rattlesnake venom enzymes that interact with components of
the hemostatic system. Toxin Rev. 2, 119e160. http://dx.doi.org/10.3109/
15569548309012695.
Markland, F.S., Kettner, C., Schiffman, S., Shaw, E., Bajwa, S.S., Reddy, K.N.,
Kirakossian, H., Patkos, G.B., Theodor, I., Pirkle, H., 1982. Kallikrein-like activity
of crotalase, a snake venom enzyme that clots ﬁbrinogen. Proc. Natl. Acad. Sci.
U. S. A. 79, 1688e1692.
Markland, F.S., Swenson, S., 2013. Snake venom metalloproteinases. Toxicon 62,
3e18. http://dx.doi.org/10.1016/j.toxicon.2012.09.004.
Massey, D.J., Calvete, J.J., Sanchez, E.E., Sanz, L., Richards, K., Curtis, R., Boesen, K.,
2012. Venom variability and envenoming severity outcomes of the Crotalus
scutulatus scutulatus (Mojave rattlesnake) from Southern Arizona. J. Proteom.
75, 2576e2587. http://dx.doi.org/10.1016/j.jprot.2012.02.035.
Masuda, S., Araki, S., Yamamoto, T., Kaji, K., Hayashi, H., 1997. Puriﬁcation of a
vascular apoptosis-inducing factor from hemorrhagic snake venom. Biochem.
Biophys. Res. Commun. 235, 59e63. http://dx.doi.org/10.1006/bbrc.1997.6728.
McCleary, R.J.R., Kini, R.M., 2012. Non-enzymatic proteins from snake venoms: a
gold mine of pharmacological tools and drug leads. Toxicon 1e19. http://
dx.doi.org/10.1016/j.toxicon.2012.09.008.
Melani, R.D., Araujo, G.D.T., Carvalho, P.C., Goto, L., Nogueira, F.C.S., Junqueira, M.,
Domont, G.B., 2015. Seeing beyond the tip of the iceberg: a deep analysis of the
venome of the Brazilian Rattlesnake, Crotalus durissus terriﬁcus. EuPA Open
Proteom. http://dx.doi.org/10.1016/j.euprot.2015.05.006.
Menin, L., Perchuc, A., Favreau, P., Perret, F., Michalet, S., Sch€oni, R., Wilmer, M.,
St€ocklin, R., 2008. High throughput screening of bradykinin-potentiating pep-
tides in Bothrops moojeni snake venom using precursor ion mass spectrometry.
Toxicon 51, 1288e1302. http://dx.doi.org/10.1016/j.toxicon.2008.02.019.
Mitra, J., Bhattacharyya, D., 2014. Phosphodiesterase from Daboia russelli russelli
venom: puriﬁcation, partial characterization and inhibition of platelet aggre-
gation. Toxicon 88C, 1e10. http://dx.doi.org/10.1016/j.toxicon.2014.06.004.
Mochca-Morales, J., Martin, B.M., Possani, L.D., 1990. Isolation and characterization
of helothermine, a novel toxin from Heloderma horridum horridum (Mexican
beaded lizard) venom. Toxicon 28, 299e309.
Munawar, A., Trusch, M., Georgieva, D., Hildebrand, D., Kwiatkowski, M.,
Behnken, H., Harder, S., Arni, R., Spencer, P., Schlüter, H., Betzel, C., 2014. Elapid
snake venom analyses show the speciﬁcity of the peptide composition at the
level of genera Naja and Notechis. Toxins Basel 6, 850e868. http://dx.doi.org/
10.3390/toxins6030850.
Murakami, M.T., Zela, S.P., Gava, L.M., Michelan-Duarte, S., Cintra, A.C.O., Arni, R.K.,
2003. Crystal structure of the platelet activator convulxin, a disulﬁde-linked
alpha4beta4 cyclic tetramer from the venom of Crotalus durissus terriﬁcus.
Biochem. Biophys. Res. Commun. 310, 478e482.
Navarro, J., Caraballo, A., Sanchez, E., Rodriguez-Acosta, A., 2004. Epidemiological
and clinical aspects of snakebite in Monagas state, Venezuela. Rev. La Fac. Med.
27, 106e110.
Oguiura, N., Boni-Mitake, M., Affonso, R., Zhang, G., 2011. In vitro antibacterial and
hemolytic activities of crotamine, a small basic myotoxin from rattlesnake
Crotalus durissus. J. Antibiot. Tokyo 64, 327e331. http://dx.doi.org/10.1038/
ja.2011.10.
Oguiura, N., Boni-Mitake, M., Radis-Baptista, G., 2005. New view on crotamine, a
small basic polypeptide myotoxin from South American rattlesnake venom.
Toxicon 46, 363e370. http://dx.doi.org/10.1016/j.toxicon.2005.06.009.
Oguiura, N., Camargo, M.E., da Silva, A.R.P., Horton, D.S.P.Q., 2000. Quantiﬁcation of
crotamine, a small basic myotoxin, in South American rattlesnake (Crotalus
durissus terriﬁcus) venom by enzyme-linked immunosorbent assay with
parallel-lines analysis. Toxicon 38, 443e448. http://dx.doi.org/10.1016/S0041-
0101(99)00157-9.
Peigneur, S., Orts, D.J.B., Prieto da Silva, A.R., Oguiura, N., Boni-Mitake, M., de
Oliveira, E.B., Zaharenko, A.J., de Freitas, J.C., Tytgat, J., 2012. Crotamine phar-
macology revisited: novel insights based on the inhibition of KV channels. Mol.
Pharmacol. 82, 90e96. http://dx.doi.org/10.1124/mol.112.078188.
Peng, L., Xu, X., Guo, M., Yan, X., Wang, S., Gao, S., Zhu, S., 2013. Effects of metal ions
and disulﬁde bonds on the activity of phosphodiesterase from Trimeresurus
stejnegeri venom. Metallomics 5, 920e927. http://dx.doi.org/10.1039/
c3mt00031a.
Peng, L., Xu, X., Shen, D., Zhang, Y., Song, J., Yan, X., Guo, M., 2011. Puriﬁcation and
partial characterization of a novel phosphodiesterase from the venom of Tri-
meresurus stejnegeri: inhibition of platelet aggregation. Biochimie 93,
1601e1609. http://dx.doi.org/10.1016/j.biochi.2011.05.027.
Perez, A.V., Rucavado, A., Sanz, L., Calvete, J.J., Gutierrez, J.M., 2008. Isolation and
characterization of a serine proteinase with thrombin-like activity from the
venom of the snake Bothrops asper. Braz. J. Med. Biol. Res. 41, 12e17.
Petersen, T.N., Brunak, S., von Heijne, G., Nielsen, H., 2011. SignalP 4.0: discrimi-
nating signal peptides from transmembrane regions. Nat. Methods 8, 785e786.
http://dx.doi.org/10.1038/nmeth.1701.
Pifano, F., Rodríguez Acosta, A., 1996. Ecological niche and redescription of Crotalus
vegrandis (Serpentes: Crotalidae) in Venezuela. Brenesia 169e175.
Pifano, F., Rodríguez Acosta, A., 1995. Sobre el emponzo~namiento producido por la
cascabel de uracoa (Crotalus vegrandis Klauber 1941), serpiente neotropical. Rev.
Fac. Med. 18, 194e196.
V.L. Viala et al. / Toxicon 107 (2015) 234e251 251Pimenta, D.C., Lebrun, I., 2007. Cryptides: buried secrets in proteins. Peptides 28,
2403e2410. http://dx.doi.org/10.1016/j.peptides.2007.10.005.
Polgar, J., Clemetson, J.M., Kehrel, B.E., Wiedemann, M., Magnenat, E.M., Wells, T.N.,
Clemetson, K.J., 1997. Platelet activation and signal transduction by convulxin, a
C-type lectin from Crotalus durissus terriﬁcus (tropical rattlesnake) venom via
the p62/GPVI collagen receptor. J. Biol. Chem. 272, 13576e13583.
Pulido-Mendez, M., Rodriguez-Acosta, A., Finol, H.J., Aguilar, I., Giron, M.E., 1999.
Ultrastructural pathology in skeletal muscle of mice envenomed with Crotalus
vegrandis venom. J. Submicrosc. Cytol. Pathol. 31, 555e561.
Rioli, V., Prezoto, B.C., Konno, K., Melo, R.L., Klitzke, C.F., Ferro, E.S., Ferreira-
Lopes, M., Camargo, A.C.M., Portaro, F.C.V., 2008. A novel bradykinin potenti-
ating peptide isolated from Bothrops jararacussu venom using catallytically
inactive oligopeptidase EP24.15. FEBS J. 275, 2442e2454. http://dx.doi.org/
10.1111/j.1742-4658.2008.06389.x.
Rodriguez-Acosta, A., Aguilar, I., Giron, M., Rodriguez-Pulido, V., 1998. Haemor-
rhagic activity of neotropical rattlesnake (Crotalus vegrandis Klauber, 1941)
venom. Nat. Toxins 6, 15e18.
Rodríguez-Acosta, A., Mondolﬁ, A., Orihuela, A., Aguilar, M., 1995. Que hacer frente a
un accidente ofídico. Venediciones, Caracas.
Rokyta, D.R., Wray, K.P., Margres, M.J., 2013. The genesis of an exceptionally lethal
venom in the timber rattlesnake (Crotalus horridus) revealed through compar-
ative venom-gland transcriptomics. BMC Genom. 14, 394. http://dx.doi.org/
10.1186/1471-2164-14-394.
Romero-Vargas, F.F., Ponce-Soto, L.A., Martins-de-Souza, D., Marangoni, S., 2010.
Biological and biochemical characterization of two new PLA2 isoforms Cdc-9
and Cdc-10 from Crotalus durissus cumanensis snake venom. Comp. Biochem.
Physiol. C. Toxicol. Pharmacol. 151, 66e74. http://dx.doi.org/10.1016/
j.cbpc.2009.08.011.
Santoro, M.L., Vaquero, T.S., Paes Leme, A.F., Serrano, S.M.T., 2009. NPP-BJ, a
nucleotide pyrophosphatase/phosphodiesterase from Bothrops jararaca snake
venom, inhibits platelet aggregation. Toxicon 54, 499e512. http://dx.doi.org/
10.1016/j.toxicon.2009.05.016.
Saviola, A.J., Pla, D., Sanz, L., Castoe, T.A., Calvete, J.J., Mackessy, S.P., 2015.
Comparative venomics of the Prairie Rattlesnake (Crotalus viridis viridis) from
Colorado: Identiﬁcation of a novel pattern of ontogenetic changes in venom
composition and assessment of the immunoreactivity of the commercial anti-
venom CroFab®. J. Proteom. 121, 28e43. http://dx.doi.org/10.1016/
j.jprot.2015.03.015.
Scannone, H., Rodríguez, O.G., Lancini, A.R., 1978. Enzymatic activities and other
characteristics of Crotalus vegrandis snake venom. In: Rosenberg, P. (Ed.),
Toxins: Animal, Plant and Microbial. International Symposium on Animal, Plant
and Microbial Toxins. Pergamon Press, San Jose, Costa Rica.
Schweitz, H., Vigne, P., Moinier, D., Frelin, C., Lazdunski, M., 1992. A new member of
the natriuretic peptide family is present in the venom of the green mamba
(Dendroaspis angusticeps). J. Biol. Chem. 267, 13928e13932.
Serrano, S.M.T., 2013. The long road of research on snake venom serine proteinases.
Toxicon 62, 19e26. http://dx.doi.org/10.1016/j.toxicon.2012.09.003.
Slotta, K.H., Fraenkel-Conrat, H., 1938. Crotoxin. Nature 144, 290e291.
Sunagar, K., Undheim, E.A.B., Scheib, H., Gren, E.C.K., Cochran, C., Person, C.E.,
Koludarov, I., Kelln, W., Hayes, W.K., King, G.F., Antunes, A., Fry, B.G., 2014.Intraspeciﬁc venom variation in the medically signiﬁcant Southern Paciﬁc
Rattlesnake (Crotalus oreganus helleri): biodiscovery, clinical and evolutionary
implications. J. Proteom. 99, 68e83. http://dx.doi.org/10.1016/
j.jprot.2014.01.013.
Tavares, N.A.C., Correia, J.M., Guarnieri, M.C., Lima-Filho, J.L., Prieto-da-Silva, A.R.B.,
Radis-Baptista, G., 2008. Expression of mRNAs coding for VAP1/crotastatin-like
metalloproteases in the venom glands of three South American pit vipers
assessed by quantitative real-time PCR. Toxicon 52, 897e907. http://dx.doi.org/
10.1016/j.toxicon.2008.08.022.
Towbin, H., Staehelin, T., Gordon, J., 1979. Electrophoretic transfer of proteins from
polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. U. S. A. 76, 4350e4354.
Toyama, M.H., Toyama, D., de, O., Passero, L.F.D., Laurenti, M.D., Corbett, C.E.,
Tomokane, T.Y., Fonseca, F.V., Antunes, E., Joazeiro, P.P., Beriam, L.O.S.,
Martins, M.A.C., Monteiro, H.S.A., Fonteles, M.C., 2006. Isolation of a new L-
amino acid oxidase from Crotalus durissus cascavella venom. Toxicon 47, 47e57.
http://dx.doi.org/10.1016/j.toxicon.2005.09.008.
Vargas, L.J., Quintana, J.C., Perea~nez, J.A., Nú~nez, V., Sanz, L., Calvete, J., 2013. Cloning
and characterization of an antibacterial l-amino acid oxidase from Crotalus
durissus cumanensis venom. Toxicon 64, 1e11. http://dx.doi.org/10.1016/
j.toxicon.2012.11.027.
Viala, V.L., Hildebrand, D., Trusch, M., Arni, R.K., Pimenta, D.C., Schlüter, H., Betzel, C.,
Spencer, P.J., 2014. Pseudechis guttatus venom proteome: insights into evolu-
tion and toxin clustering. J. Proteom. 110C, 32e44. http://dx.doi.org/10.1016/
j.jprot.2014.07.030.
Wang, Y.-L., Kuo, J.-H., Lee, S.-C., Liu, J.-S., Hsieh, Y.-C., Shih, Y.-T., Chen, C.-J., Chiu, J.-
J., Wu, W.-G., 2010. Cobra CRISP functions as an inﬂammatory modulator via a
novel Zn2þ- and heparan sulfate-dependent transcriptional regulation of
endothelial cell adhesion molecules. J. Biol. Chem. 285, 37872e37883. http://
dx.doi.org/10.1074/jbc.M110.146290.
Yamane, E.S., Bizerra, F.C., Oliveira, E.B., Moreira, J.T., Rajabi, M., Nunes, G.L.C., de
Souza, A.O., da Silva, I.D.C.G., Yamane, T., Karpel, R.L., Silva, P.I., Hayashi, M.A.F.,
2013. Unraveling the antifungal activity of a South American rattlesnake toxin
crotamine. Biochimie 95, 231e240. http://dx.doi.org/10.1016/
j.biochi.2012.09.019.
Yamazaki, Y., Hyodo, F., Morita, T., 2003. Wide distribution of cysteine-rich secretory
proteins in snake venoms: isolation and cloning of novel snake venom cysteine-
rich secretory proteins. Arch. Biochem. Biophys. 412, 133e141. http://dx.doi.org/
10.1016/S0003-9861(03)00028-6.
Yamazaki, Y., Morita, T., 2004. Structure and function of snake venom cysteine-rich
secretory proteins. Toxicon 44, 227e231. http://dx.doi.org/10.1016/
j.toxicon.2004.05.023.
Yonamine, C.M., Prieto-da-Silva, A.R.B., Magalh~aes, G.S., Radis-Baptista, G.,
Morganti, L., Ambiel, F.C., Chura-Chambi, R.M., Yamane, T., Camillo, M.A.P., 2009.
Cloning of serine protease cDNAs from Crotalus durissus terriﬁcus venom gland
and expression of a functional Gyroxin homologue in COS-7 cells. Toxicon 54,
110e120. http://dx.doi.org/10.1016/j.toxicon.2009.03.022.
Yoshida-Kanashiro, E., Navarrete, L.F., Rodríguez-Acosta, A., 2003. On the unusual
hemorrhagic and necrotic activities caused by the rattlesnake (Crotalus durissus
cumanensis) in a Venezuelan patient. Rev. Cuba. Med. Trop. 55, 38e40.
